NCT06673134View on ClinicalTrials.gov

Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 24, 2026

Study Completion Date

July 24, 2028

Conditions
Crohn Disease
Interventions
DRUG

enteral nutrition

exclusive enteral nutrition therapy or Partial enteral nutrition

DRUG

Immunotherapy

Immunosuppressants therapy, Including thalidomide, azathioprine, methotrexate, etc

DRUG

biological agents

Inflixima , domestic infliximab (Taizhou Mabtech Pharmaceutical Co.,Ltd) and Adalimumab , etc

DRUG

Glucocorticoids

Glucocorticoids treatments are given

OTHER

fecal microbiota transplantation

Fecal bacteria transplantation treatment, transplantation routes include enema, TET route, capsule fecal bacteria route, etc

Trial Locations (1)

430030

Tongji Hospital, Wuhan, 430030, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER

NCT06673134 - Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease | Biotech Hunter | Biotech Hunter